1. Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan-Karnak, Sara Redenšek Trampuž, Vita Dolžan, 2022, pregledni znanstveni članek Ključne besede: COVID-19, oxidative stress, genetics, antioxidant enzymes, anti-oxidative therapies, glutathione, N-acetylcysteine Celotno besedilo (datoteka, 2,25 MB) Gradivo ima več datotek! Več... |
|
3. Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s diseaseSara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, izvirni znanstveni članek Ključne besede: Parkinson’s disease, motor complications, visual hallucinations, impulse control disorders, dyskinesia, polymorphism, serotonin, adverse event, pharmacogenomics Celotno besedilo (datoteka, 550,02 KB) Gradivo ima več datotek! Več... |
4. Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's diseaseSara Redenšek Trampuž, Barbara Jenko Bizjan, Maja Trošt, Vita Dolžan, 2020, izvirni znanstveni članek Ključne besede: Parkinson's disease, polymorphism, pharmacogenetics, impulse control disorders, predictive model, psychiatric complications, visual hallucinations Celotno besedilo (datoteka, 3,37 MB) Gradivo ima več datotek! Več... |
5. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, izvirni znanstveni članek Ključne besede: Parkinson's disease, susceptibility, polymorphism, inflammation, oxidative stress, adverse events Celotno besedilo (datoteka, 673,75 KB) Gradivo ima več datotek! Več... |
6. Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's diseaseSara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan, 2019, izvirni znanstveni članek Ključne besede: Parkinson's disease, genetic polymorphism, dopaminergic pathway, personalized medicine, adverse events Celotno besedilo (datoteka, 411,70 KB) Gradivo ima več datotek! Več... |
7. Assessment of the telomere length and its effect on the symptomatology of Parkinson's diseaseTina Levstek, Sara Redenšek Trampuž, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek, 2021, izvirni znanstveni članek Ključne besede: Parkinson's disease, telomere length, levodopa treatment, telomere attrition, dementia Celotno besedilo (datoteka, 737,20 KB) Gradivo ima več datotek! Več... |
|
9. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse eventsSara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, izvirni znanstveni članek Ključne besede: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism Celotno besedilo (datoteka, 279,78 KB) Gradivo ima več datotek! Več... |
10. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s diseaseBoštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec, 2023, izvirni znanstveni članek Ključne besede: Parkinson disease, cognitive impairment, paraoxonase 1, paraoxonase activity, single-nucleotide polymorphisms, iFIT Celotno besedilo (datoteka, 1,14 MB) Gradivo ima več datotek! Več... |